載入...

Product review on the Anti-PD-L1 antibody atezolizumab

Immunotherapy as a therapeutic strategy has seized the narrative throughout clinical oncology over the past few years. Once considered a niche treatment for rare cancers, immunotherapy has quickly emerged as the standard of care for many common cancer types. The remarkable rise is largely due to the...

全面介紹

Na minha lista:
書目詳細資料
發表在:Hum Vaccin Immunother
Main Authors: Shah, Neil J., Kelly, William J., Liu, Stephen V., Choquette, Karin, Spira, Alexander
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5806639/
https://ncbi.nlm.nih.gov/pubmed/29194007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1403694
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!